Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 6;11(23):e026644.
doi: 10.1161/JAHA.122.026644. Epub 2022 Nov 23.

Persistent Asthma Is Associated With Carotid Plaque in MESA

Affiliations

Persistent Asthma Is Associated With Carotid Plaque in MESA

Matthew C Tattersall et al. J Am Heart Assoc. .

Abstract

Background Asthma and atherosclerotic cardiovascular disease share an underlying inflammatory pathophysiology. We hypothesized that persistent asthma is associated with carotid plaque burden, a strong predictor of atherosclerotic cardiovascular disease events. Methods and Results The MESA (Multi-Ethnic Study of Atherosclerosis) enrolled adults free of known atherosclerotic cardiovascular disease at baseline. Subtype of asthma was determined at examination 1. Persistent asthma was defined as asthma requiring use of controller medications, and intermittent asthma was defined as asthma without controller medications. B-mode carotid ultrasound was performed to detect carotid plaques (total plaque score [TPS], range 0-12). Multivariable regression modeling with robust variances evaluated the association of asthma subtype and carotid plaque burden. The 5029 participants were a mean (SD) age of 61.6 (10.0) years (53% were women, 26% were Black individuals, 23% were Hispanic individuals, and 12% were Chinese individuals). Carotid plaque was present in 50.5% of participants without asthma (TPS, 1.29 [1.80]), 49.5% of participants with intermittent asthma (TPS, 1.25 [1.76]), and 67% of participants with persistent asthma (TPS, 2.08 [2.35]) (P≤0.003). Participants with persistent asthma had higher interleukin-6 (1.89 [1.61] pg/mL) than participants without asthma (1.52 [1.21] pg/mL; P=0.02). In fully adjusted models, persistent asthma was associated with carotid plaque presence (odds ratio, 1.83 [95% confidence interval, 1.21-2.76]; P<0.001) and TPS (β=0.66; P<0.01), without attenuation after adjustment for baseline interleukin-6 (P=0.02) or CRP (C-reactive protein) (P=0.01). Conclusions Participants with persistent asthma had higher carotid plaque burden and higher levels of inflammatory biomarkers, compared with participants without asthma. Adjustment for baseline inflammatory biomarkers did not attenuate the association between carotid plaque and asthma subtype, highlighting the increased atherosclerotic cardiovascular disease risk among those with persistent asthma may be multifactorial.

Keywords: asthma; carotid plaque; inflammation.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flow diagram of included participants.
Figure 2
Figure 2. Association of carotid plaque presence and asthma subtype with and without adjustment for baseline inflammatory markers.
Model 3, adjusted for age, sex, race, body mass index, systolic blood pressure, tobacco use, total cholesterol, high‐density lipoprotein cholesterol, education, statin medication use, antihypertensive medication use, and diabetes. CRP indicates C‐reactive protein; and IL‐6, interleukin‐6.

Comment in

  • Asthma and carotid artery plaques.
    Cardet JC, Weare-Regales N, Lockey RF. Cardet JC, et al. J Allergy Clin Immunol. 2023 May;151(5):1257-1258. doi: 10.1016/j.jaci.2023.02.022. Epub 2023 Mar 2. J Allergy Clin Immunol. 2023. PMID: 36868322 No abstract available.
  • Asthma begünstigt offenbar Atherosklerose.
    Pizarro C, Skowasch D. Pizarro C, et al. MMW Fortschr Med. 2023 Jun;165(12):22-23. doi: 10.1007/s15006-023-2788-0. MMW Fortschr Med. 2023. PMID: 37322200 Review. German. No abstract available.

Similar articles

Cited by

References

    1. Akinbami LJ, Moorman JE, Bailey C, Zahran HS, King M, Johnson CA, Liu X. Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. NCHS Data Brief. 2012;94:1–8. - PubMed
    1. Ridker PM, Hennekens CH, Buring JE, Rifai N. C‐reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843. doi: 10.1056/nejm200003233421202 - DOI - PubMed
    1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979. doi: 10.1056/nejm199704033361401 - DOI - PubMed
    1. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, et al. Rosuvastatin to prevent vascular events in men and women with elevated C‐reactive protein. N Engl J Med. 2008;359:2195–2207. doi: 10.1056/NEJMoa0807646 - DOI - PubMed
    1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al. Heart disease and stroke statistics‐‐2014 update: a report from the American Heart Association. Circulation. 2014;129:e28–e292. doi: 10.1161/01.cir.0000441139.02102.80 - DOI - PMC - PubMed

Publication types